sulmazole has been researched along with indolidan in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forest, MC; Lahouratate, P; Martin, M; Nadler, G; Quiniou, MJ; Zimmermann, RG | 1 |
| Coates, WJ; Connolly, B; Dhanak, D; Flynn, ST; Worby, A | 1 |
| Sandusky, GE; Tamura, RN; Vodicnik, MJ | 1 |
3 other study(ies) available for sulmazole and indolidan
| Article | Year |
|---|---|
A novel class of cardiotonic agents: synthesis and biological evaluation of 5-substituted 3,6-dihydrothiadiazin-2-ones with cyclic AMP phosphodiesterase inhibiting and myofibrillar calcium sensitizing properties.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Calcium; Cardiotonic Agents; Dogs; Female; Guinea Pigs; Heart; Indoles; Male; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Structure-Activity Relationship; Thiadiazines | 1992 |
Cyclic nucleotide phosphodiesterase inhibition by imidazopyridines: analogues of sulmazole and isomazole as inhibitors of the cGMP specific phosphodiesterase.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Imidazoles; Isoenzymes; Phosphodiesterase Inhibitors; Pyridines; Structure-Activity Relationship | 1993 |
Cardiovascular and adrenal proliferative lesions in Fischer 344 rats induced by long-term treatment with type III phosphodiesterase inhibitors (positive inotropic agents), isomazole and indolidan.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Animals; Body Weight; Cardiotonic Agents; Cardiovascular Diseases; Eating; Female; Imidazoles; Indoles; Male; Organ Size; Oxindoles; Pheochromocytoma; Phosphodiesterase Inhibitors; Pyridazines; Rats; Rats, Inbred F344 | 1991 |